retatrutide trial weight loss (“reta”) is an experimental weight-loss drug currently in Phase 3 clinical trials. It's a once-weekly injection similar to Ozempic and Mounjaro—but more powerful. The reason comes down to how it works Retatrutide improves blood sugar and

Olympia competitors converging on the same compoundI pay attention

Aroda, B.S

2 Department of Internal Medicine, Lahore General Hospital, Ameer-Ud-Din Medical College, Lahore, Punjab, Pakistan Correspondence: Hongwei Jiang, Department of Metabolism and Endocrinology, Endocrine and Metabolic Disease Center, The First Affiliated Hospital and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, Peoples Republic of China, Email [email protected] Abstract: Adolescent obesity is an escalating global health concern associated with increased risks of cardiovascular disease, type 2 diabetes mellitus, and long-term metabolic complications

The first study was done by Gutniak et al

In the stomach, it slows gastric emptying, meaning food stays in your digestive system longer and you feel satisfied with smaller meals

The interest in this potential effect stems from the understanding that GLP-1 receptors are present in brain regions associated with reward processing and addictive behaviours